INNOCARE PHARMA LIMITED

Transcripts InnoCare Pharma Limited

Equities

9969

KYG4783B1032

Delayed Hong Kong S.E. Other stock markets 09:55:34 2024-05-09 pm EDT			5-day change	1st Jan Change
5.16 ^HKD	-0.19%		-1.53%	-25.11%

Mar. 29	InnoCare Pharma Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib	CI
Mar. 28	Transcript : InnoCare Pharma Limited, 2023 Earnings Call, Mar 28, 2024

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : InnoCare Pharma Limited, 2023 Earnings Call, Mar 28, 2024	Mar. 28
Transcript : InnoCare Pharma Limited Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 08:30 AM	Jan. 10
Transcript : InnoCare Pharma Limited, H1 2023 Earnings Call, Aug 30, 2023	23-08-30
Innocare Pharma Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022	22-08-04	CI
InnoCare Pharma Limited Provides Earnings Guidance for the Year Ended December 31, 2021	22-02-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW